Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Wynne

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case reviewSuchika Garg, Karen Wynne, Ebun Omoyinmi, et al.
Frontiers in Pediatrics|May 16, 2022
Hereditary Systemic Autoinflammatory Diseases: Therapeutic StratificationOvgu Kul Cinar, Amber Putland, Karen Wynne, et al.
Pediatric Rheumatology Online Journal|July 10, 2019
Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndromeAbdulkadir A Elmi, Karen Wynne, Iek L Cheng, et al.
Rheumatology (Oxford, England)|December 20, 2013
Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experienceRicardo A G Russo, Sonia Melo-Gomes, Helen J Lachmann, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case reviewSuchika Garg, Karen Wynne, Ebun Omoyinmi, et al.
Frontiers in Pediatrics|May 16, 2022
Hereditary Systemic Autoinflammatory Diseases: Therapeutic StratificationOvgu Kul Cinar, Amber Putland, Karen Wynne, et al.
Pediatric Rheumatology Online Journal|July 10, 2019
Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndromeAbdulkadir A Elmi, Karen Wynne, Iek L Cheng, et al.
Rheumatology (Oxford, England)|December 20, 2013
Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experienceRicardo A G Russo, Sonia Melo-Gomes, Helen J Lachmann, et al.
Pageof 1